Illumina has also gathered £20m ($25m) to every graduate from its UK-based accelerator.

Illumina, a Nasdaq-listed DNA sequencing company, has selected nine genomics companies to join its accelerators in the US and UK. Illumina has also gathered £20m ($25m) in pound-for-pound match funding to every graduate from its UK-based accelerator that secures between £500,000 and up to £4m in qualified new capital within one year of graduation. LifeArc,…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.